BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 31902917)

  • 1. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
    Fujii M
    Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
    Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
    Front Immunol; 2021; 12():696784. PubMed ID: 34276687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
    Melnik BC
    Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.
    Lou H; Lu J; Choi EB; Oh MH; Jeong M; Barmettler S; Zhu Z; Zheng T
    J Immunol; 2017 Apr; 198(7):2543-2555. PubMed ID: 28228560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.
    Oh JS; Seong GS; Kim YD; Choung SY
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of impaired Notch signalling in atopic dermatitis.
    Melnik BC
    Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for itch and disease severity in atopic dermatitis.
    Lee CH; Yu HS
    Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
    Kabashima K
    J Dermatol Sci; 2013 Apr; 70(1):3-11. PubMed ID: 23473856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics and recent advances in the pathophysiology of atopic dermatitis.
    Nakahara T; Kido-Nakahara M; Tsuji G; Furue M
    J Dermatol; 2021 Feb; 48(2):130-139. PubMed ID: 33118662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
    Mollanazar NK; Smith PK; Yosipovitch G
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):263-292. PubMed ID: 25931325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morus alba fruits attenuates atopic dermatitis symptoms and pathology in vivo and in vitro via the regulation of barrier function, immune response and pruritus.
    Kim HM; Kang YM; Jin BR; Lee H; Lee DS; Lee M; An HJ
    Phytomedicine; 2023 Jan; 109():154579. PubMed ID: 36610150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis.
    Buhl T; Ikoma A; Kempkes C; Cevikbas F; Sulk M; Buddenkotte J; Akiyama T; Crumrine D; Camerer E; Carstens E; Schön MP; Elias P; Coughlin SR; Steinhoff M
    Front Immunol; 2020; 11():1740. PubMed ID: 32903402
    [No Abstract]   [Full Text] [Related]  

  • 13. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
    Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
    Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis.
    Jariwala SP; Abrams E; Benson A; Fodeman J; Zheng T
    Clin Exp Allergy; 2011 Nov; 41(11):1515-20. PubMed ID: 21672057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33 in atopic dermatitis.
    Imai Y
    J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E
    Sawada Y; Honda T; Nakamizo S; Nakajima S; Nonomura Y; Otsuka A; Egawa G; Yoshimoto T; Nakamura M; Narumiya S; Kabashima K
    J Allergy Clin Immunol; 2019 Nov; 144(5):1265-1273.e9. PubMed ID: 31301371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms in atopic dermatitis.
    Oyoshi MK; He R; Kumar L; Yoon J; Geha RS
    Adv Immunol; 2009; 102():135-226. PubMed ID: 19477321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into atopic dermatitis gained from genetically defined mouse models.
    Nakajima S; Nomura T; Common J; Kabashima K
    J Allergy Clin Immunol; 2019 Jan; 143(1):13-25. PubMed ID: 30612664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.
    Wong LS; Wu T; Lee CH
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 25, thymic stromal lymphopoietin and house dust mites in pathogenesis of atopic dermatitis.
    Jaworek AK; Szafraniec K; Zuber Z; Wojas-Pelc A; Jaworek J
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32776912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.